secwatch.observer — SEC 8-K summary
======================================

Issuer:     Milestone Pharmaceuticals Inc. (MIST)
CIK:        0001408443
Form:       8-K
Filed at:   2024-03-04T23:59:59+00:00
Accession:  0001104659-24-030267
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Milestone Pharmaceuticals prices $30M public offering; net proceeds ~$32.4M
---------------------------------------------------------------------------

- Offering of 16,666,667 common shares at $1.50/share and 3,333,333 pre-funded warrants at $1.499/warrant.
- Underwriters' option for 3,000,000 additional common shares exercised in full.
- Net proceeds of ~$32.4M to fund etripamil development for PSVT and AFib-RVR, plus working capital.
- Expected to close on or about March 4, 2024, subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1408443/000110465924030267/0001104659-24-030267-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1408443/000110465924030267/tm247820d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-030267

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer